Reshaping of the gastrointestinal microbiome alters atherosclerotic plaque inflammation resolution in mice
Abstract Since alterations in the intestinal microbiota may induce systemic inflammation and polarization of macrophages to the M1 state, the microbiome role in atherosclerosis, an M1-driven disease, requires evaluation. We aimed to determine if antibiotic (Abx) induced alterations to the intestinal...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a8f3dfa3b18f42a5b4b2ebab1cb9df7e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:a8f3dfa3b18f42a5b4b2ebab1cb9df7e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:a8f3dfa3b18f42a5b4b2ebab1cb9df7e2021-12-02T13:40:51ZReshaping of the gastrointestinal microbiome alters atherosclerotic plaque inflammation resolution in mice10.1038/s41598-021-88479-y2045-2322https://doaj.org/article/a8f3dfa3b18f42a5b4b2ebab1cb9df7e2021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-88479-yhttps://doaj.org/toc/2045-2322Abstract Since alterations in the intestinal microbiota may induce systemic inflammation and polarization of macrophages to the M1 state, the microbiome role in atherosclerosis, an M1-driven disease, requires evaluation. We aimed to determine if antibiotic (Abx) induced alterations to the intestinal microbiota interferes with atherosclerotic plaque inflammation resolution after lipid-lowering in mice. Hyperlipidemic Apoe −/− mice were fed a western diet to develop aortic atherosclerosis with aortas then transplanted into normolipidemic wild-type (WT) mice to model clinically aggressive lipid management and promote atherosclerosis inflammation resolution. Gut microbial composition pre and post-transplant was altered via an enteral antibiotic or not. Post aortic transplant, after Abx treatment, while plaque size did not differ, compared to Apoe −/− mice, Abx– WT recipient mice had a 32% reduction in CD68-expressing cells (p = 0.02) vs. a non-significant 12% reduction in Abx+ WT mice. A trend toward an M1 plaque CD68-expresing cell phenotype was noted in Abx+ mice. By 16S rRNA sequence analysis, the Abx+ mice had reduced alpha diversity and increased Firmicutes/Bacteroidetes relative abundance ratio with a correlation between gut Firmicutes abundance and plaque CD68-expressing cell content (p < 0.05). These results indicate that in a murine atherosclerotic plaque inflammation resolution model, antibiotic-induced microbiome perturbation may blunt the effectiveness of lipid-lowering to reduce the content of plaque inflammatory CD68-expressing cells.Michael S. GarshickCyrus NikainMichael TawilStephanie PenaTessa J. BarrettBenjamin G. WuZhan GaoMartin J. BlaserEdward A. FisherNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Michael S. Garshick Cyrus Nikain Michael Tawil Stephanie Pena Tessa J. Barrett Benjamin G. Wu Zhan Gao Martin J. Blaser Edward A. Fisher Reshaping of the gastrointestinal microbiome alters atherosclerotic plaque inflammation resolution in mice |
description |
Abstract Since alterations in the intestinal microbiota may induce systemic inflammation and polarization of macrophages to the M1 state, the microbiome role in atherosclerosis, an M1-driven disease, requires evaluation. We aimed to determine if antibiotic (Abx) induced alterations to the intestinal microbiota interferes with atherosclerotic plaque inflammation resolution after lipid-lowering in mice. Hyperlipidemic Apoe −/− mice were fed a western diet to develop aortic atherosclerosis with aortas then transplanted into normolipidemic wild-type (WT) mice to model clinically aggressive lipid management and promote atherosclerosis inflammation resolution. Gut microbial composition pre and post-transplant was altered via an enteral antibiotic or not. Post aortic transplant, after Abx treatment, while plaque size did not differ, compared to Apoe −/− mice, Abx– WT recipient mice had a 32% reduction in CD68-expressing cells (p = 0.02) vs. a non-significant 12% reduction in Abx+ WT mice. A trend toward an M1 plaque CD68-expresing cell phenotype was noted in Abx+ mice. By 16S rRNA sequence analysis, the Abx+ mice had reduced alpha diversity and increased Firmicutes/Bacteroidetes relative abundance ratio with a correlation between gut Firmicutes abundance and plaque CD68-expressing cell content (p < 0.05). These results indicate that in a murine atherosclerotic plaque inflammation resolution model, antibiotic-induced microbiome perturbation may blunt the effectiveness of lipid-lowering to reduce the content of plaque inflammatory CD68-expressing cells. |
format |
article |
author |
Michael S. Garshick Cyrus Nikain Michael Tawil Stephanie Pena Tessa J. Barrett Benjamin G. Wu Zhan Gao Martin J. Blaser Edward A. Fisher |
author_facet |
Michael S. Garshick Cyrus Nikain Michael Tawil Stephanie Pena Tessa J. Barrett Benjamin G. Wu Zhan Gao Martin J. Blaser Edward A. Fisher |
author_sort |
Michael S. Garshick |
title |
Reshaping of the gastrointestinal microbiome alters atherosclerotic plaque inflammation resolution in mice |
title_short |
Reshaping of the gastrointestinal microbiome alters atherosclerotic plaque inflammation resolution in mice |
title_full |
Reshaping of the gastrointestinal microbiome alters atherosclerotic plaque inflammation resolution in mice |
title_fullStr |
Reshaping of the gastrointestinal microbiome alters atherosclerotic plaque inflammation resolution in mice |
title_full_unstemmed |
Reshaping of the gastrointestinal microbiome alters atherosclerotic plaque inflammation resolution in mice |
title_sort |
reshaping of the gastrointestinal microbiome alters atherosclerotic plaque inflammation resolution in mice |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/a8f3dfa3b18f42a5b4b2ebab1cb9df7e |
work_keys_str_mv |
AT michaelsgarshick reshapingofthegastrointestinalmicrobiomealtersatheroscleroticplaqueinflammationresolutioninmice AT cyrusnikain reshapingofthegastrointestinalmicrobiomealtersatheroscleroticplaqueinflammationresolutioninmice AT michaeltawil reshapingofthegastrointestinalmicrobiomealtersatheroscleroticplaqueinflammationresolutioninmice AT stephaniepena reshapingofthegastrointestinalmicrobiomealtersatheroscleroticplaqueinflammationresolutioninmice AT tessajbarrett reshapingofthegastrointestinalmicrobiomealtersatheroscleroticplaqueinflammationresolutioninmice AT benjamingwu reshapingofthegastrointestinalmicrobiomealtersatheroscleroticplaqueinflammationresolutioninmice AT zhangao reshapingofthegastrointestinalmicrobiomealtersatheroscleroticplaqueinflammationresolutioninmice AT martinjblaser reshapingofthegastrointestinalmicrobiomealtersatheroscleroticplaqueinflammationresolutioninmice AT edwardafisher reshapingofthegastrointestinalmicrobiomealtersatheroscleroticplaqueinflammationresolutioninmice |
_version_ |
1718392637003661312 |